Verastem | VSTM - Market Capitalization


Verastem reported $216.8M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Alaunos Therapeutics USD 6M 1000K Jun/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Curis USD 22M 9M Mar/2026
Cytokinetics USD 7.51B 1.66B Nov/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Incyte USD 24.6B 1.95B Sep/2026
Laboratory Of America USD 24.99B 2.03B Sep/2026
Novartis USD 292.09B 51.5B Sep/2026
Pfizer USD 165.12B 1.71B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
TG Therapeutics USD 9.79B 1.25B Nov/2026
Verastem USD 466M 130M Mar/2026